Macular amyloidosis

Macular amyloidosis (MA) is a rare chronic form of cutaneous amyloidosis (see this term), a skin disease characterized by the accumulation of amyloid deposits in the dermis, clinically characterized by pruritic hyperkeratotic gray-brown macules that give a rippled or reticulated pattern of pigmentation usually in the upper back and extensor sites of arms, forearms and legs, and histologically by the deposition of amyloid in the upper dermis and close to the basal cell layer of the epidermis. MA is commonly associated with other skin diseases, such as atopic dermatitis.

Macroprolactinoma

A pituitary prolactin cell adenoma of more than 10 mm diameter.


Total: 11

                       


(per page)
PMID (PMCID)
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
This report intends to highlight this novel association of macular amyloidosis and macroprolactinoma.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.
26662655
 MALE Adult
Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D, Ahuja A, Sharma L, Bhardwaj M, Kulshreshtha B.
Endokrynol Pol. 2015;66(6):555-8.
Temporal profile of the disease characterised by symptoms of macroprolactinoma preceding onset of macular amyloidosis with resolution of symptoms of macroprolactinoma, accompanied by reductions in prolactin, and concomitant improvement in macular amyloidosis with cabergoline therapy may suggest some link between macroprolactinoma and macular amyloidosis.